It seems that solexa prefer to sequencing higher GC content region. Does anybody face to this problem?
-
-
Yes, we have run into this phenomenon. It is also mentioned here: Dohm et al., Substantial biases in ultra-short read data sets from
high-throughput DNA sequencing, Nucleic Acids Research, 2008, 1–10
(doi:10.1093/nar/gkn425) -
Thanks. I also have read that paper, but they deal with beta genome etc.Comment
-
Any thoughts on GC content bias on the depth of coverage? I would like to see evened-out depth of coverage by taking GC-content into account; but it doesnt look even from the R linear model linearization I tried!--
bioinfosmComment
-
Are you sure it doesn't come from the library preparation?
If you read this article:
you'll see that in the last purification step, when you extract your PCR from the gel, you can improve A-T rich sequence representation by melting agarose at room temperature...
Did you try to compare a RT melted sample and a 50° melted sample?Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment